-
Published02/06/2025
-
Deadline02/07/2025
-
Opening of tenders02/07/2025
-
Today14/07/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Framework agreement for the supply of drugs program ONCOLOGY, RARE DISEASES, DIABETES, ENDOCRINES Text automatically translated in your browsing language Automatically translated
Framework agreement for the supply of drugs program ONCOLOGY, RARE DISEASES, ENDOCRINES, DIABET,. The description and quantities in the framework agreement and subsequent contracts are specified in the Tender Specifications and in the list of lots in this documentation and are exclusive of VAT, as this field does not allow the insertion of all information. The contracting authority will respond clearly and completely to all requests for clarification/additional information in accordance with Article 161 of Law No 98/2016 on the 11th day before the deadline for submission of tenders; Number of days until which clarifications can be requested before the deadline for submission of tenders: 18. Text automatically translated in your browsing language Automatically translated
https://www.e-licitatie.ro
https://www.e-licitatie.ro
33600000 - Pharmaceutical products
33652000 - Antineoplastic and immunomodulating agents
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system CVP code deduced from the text of the procedure AI-generated
33621000 - Medicinal products for the blood and blood-forming organs CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.